Solutions / Cancer Support
Cell Therapy for Cancer Support
Cancer treatment has been transformed by immunotherapy. Regenex Asia manufactures three immunotherapy products, each working through a different mechanism. All are framed as supportive immunotherapy designed to complement conventional oncology treatment.
Therapies
Which Regenex Therapies Apply
| Therapy | Role | Best For |
|---|---|---|
| NK Cell Therapy | Expanded natural killer cells targeting cancer through innate immune mechanisms. | Supportive immunotherapy. Blood and solid cancers. Post-treatment immune reconstitution. |
| CAR-T Cell Therapy | Patient's T-cells genetically engineered to target specific cancer antigens. | Relapsed/refractory blood cancers: B-cell ALL, DLBCL, multiple myeloma. |
| CIK Cell Therapy | Mixed immune cell population with T-cell and NK cell characteristics. | Supportive immunotherapy during or after conventional treatment. Solid tumours. |
Our recommendation: Choosing the right immunotherapy depends on cancer type, disease stage and clinical assessment. Our team works with your oncologist.
Discuss Cancer Immunotherapy
Our medical team works alongside your oncologist to assess which immunotherapy may be appropriate.